Hollow three-dimensional endothelialized microvessel networks based on femtosecond laser ablation

In this study, a novel method for the fabrication of hollow three-dimensional (3D) poly(lactic-co-glycolic acid) (PLGA) microvessel scaffolds is proposed. In this novel fabrication method, a salt ingot, which was used as a temporary frame to define the shape of the desired scaffold, was fabricated by extrusion molding. The salt ingot was immersed in a PLGA solution and the PGLA enveloped the ingot entirely. The femtosecond laser ablation technique was used for ablating the desired pattern on the PLGA layer and then the salt ingot was completely dissolved in distilled deionized water. A hollow 3D PLGA scaffold was obtained using this process on which bovine endothelial cells (BECs) were then cultured. Scanning electron microscopy (SEM) and fluorescent images of the cell seeding demonstrate that the BECs adhered and grew well on both the side-wall of the branches and the surroundings of each branch.     

Immunohistochemical expression of RANKL, RANK, and OPG in human oral squamous cell carcinoma

Background:  The mechanism of oral squamous cell carcinoma (SCC) invading jawbone remains controversial. Interactions between receptor activator of NF-κB (RANK) and its ligand (RANKL) are required for osteoclastogenesis. The binding of RANK and RANKL induces differentiation of osteoclasts, leading to bony destruction. Osteoprotegerin (OPG), a decoy receptor for RANKL, also binds to RANKL by competing with RANK, and this could protect against osseous destruction.
Materials and methods:  Immunoexpression of RANKL, RANK, and OPG in 25 cases of human buccal SCCs without bony invasion and 15 cases of gingival SCCs with mandibular bony invasion was investigated. Normal oral mucosa from five individuals without betel-quid chewing or cigarette smoking was used as a control. The scores are designated as percentage of positive staining × intensity of staining for each section.
Results:  Strong cytoplasmic staining of RANKL proteins is detected in cancer cells of both buccal and gingival SCCs. The same protein is identified in cytoplasm of osteoclasts for all cases involving bony invasion. Strong cytoplasmic staining of RANKL is confined to basal layer for all normal mucosa. A similar staining pattern is noted for RANK protein in all buccal and gingival SCCs. An absence of staining of RANK protein is noted for all normal tissues. Weak to negative cytoplasmic stained OPG protein is present in all buccal and gingival SCCs, but is absent in all normal tissues.
Conclusion:  These findings suggest the potential value of the RANK/RANKL/OPG pathway as biomarkers in human oral SCCs.     

Primary signet ring cell carcinoma of the cervix: A case report with review of the literature

Objective

Primary cervical signet ring cell carcinoma (PCSRCC) is extremely rare. In this paper, we describe a Case presenting with PCSRCC.

p53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy

One hundred and thirty-eight stage II and III colorectal cancer patients were included to evaluate the prognostic significance of genetic markers (including mutations of the p53, K-ras genes, and microsatellite instability) on the response to 5-fluorouracil (FU)-based post-operative adjuvant therapies (PAT). When stratified by PAT and adjusting for other prognostic variables, presence of p53 mutation was associated with a poor outcome (hazard ratio (HR)=3.1, 95% confidence interval (CI), 0.9-11.0) among patients without PAT. Our data confirmed that p53 mutation is an independent pre-treatment factor in stage II and III colorectal cancer after curative resection.     

Differentiating pyopneumothorax and peripheral lung abscess: chest ultrasonography

BACKGROUND: Differentiation between pyopneumothorax and lung abscess can be difficult but has important therapeutic consequences. The role of chest ultrasonography in this issue remains undetermined. Sonographic features of hydropneumothorax and/or pyopneumothorax are characteristic and not difficult to recognize. In this study, the authors evaluate the usefulness of a panel of sonographic findings characteristic of hydropneumothorax in distinguishing pyopneumothorax from lung abscess. METHODS: This series included 16 patients with lung abscess and 19 with pyopneumothorax. A diagnosis of lung abscess or pyopneumothorax was based on the following criteria: pus aspiration from the lesion, appropriate clinical setting, thoracic computed tomographic findings, serial follow-up of chest radiograms, and consistent clinical course. The panel of sonographic features suggestive of hydropneumothorax, including the presence of air-fluid level, the curtain sign, loss of gliding sign above the air-fluid level, and the suspended microbubble sign, were recorded and analyzed by a consensus of blinded readers. In addition, sonographic features used to differentiate empyema and lung abscess were also evaluated. RESULTS: The results indicated that the presence of air-fluid level, the curtain sign, loss of gliding sign above the air-fluid level, and the suspended microbubble sign were valuable in distinguishing pyopneumothorax from lung abscess. All four sonographic findings were observed in 17 of 19 patients with pyopneumothorax. In contrast, two or fewer sonographic findings were seen in 16 patients with lung abscess. Our results confirmed that the wall characteristics, shape of the lesion, chest wall angle, and pleural separation were also useful. CONCLUSIONS: The panel of sonographic findings is of considerable value in differentiating pyopneumothorax and lung abscess.     

Thrombotic thrombocytopenic purpura (TTP): initial treatment with plasma exchange plus steroids and immunosuppressive agents for relapsing cases

BACKGROUND: The thrombotic thrombocytopenic purpura (TTP) is a rare disorder with a high mortality rate if untreated or delayed therapy. Whether immediate diagnosis and promptly treated with plasma exchange can change the grave prognosis? METHOD: Retrospective analysis was performed on clinical characteristics and treatment outcome of 13 patients diagnosed and treated during a 6-year period, from August 1994 to August 2000, in a tertiary care university hospital in Taiwan. RESULTS: Among the patients, 8 were males and 5 were females, 10 were idiopathic, 2 were ticlopidine, and 1 was SLE-induced; 12 (92.3%) had neurological abnormalities, 11 (84.6%) had ecchymosis, 8 (61.5%) had fever, and 6 (46.2%) had renal impairment (creatinine > or = 1.5 mg/dL) at initial presentation of the syndrome. Excluding the SLE patient, 6 of 10 (60%) had shown antinuclear antibody (ANA) non-specific positive (titer > or = 1:40). All patients were initially treated with plasma exchange plus steroids. Of these 13 patients, 11 (84.6%) achieved complete remission, one had partial remission, and one, which was ticlopidine-induced, had no response and died of a progressive disease complicated with pneumonia. Within a median follow-up period of 31 months, 4 of 11 patients who achieved complete remission relapsed after one week, two weeks, three weeks, and three months, respectively. In the four relapsing patients, three late relapsing patients received FFP infusion, increased steroid dosages, added cyclophosphamide plus vincristine; and one early relapsing patient, relapsing twice, received an additional two courses of plasma exchange and added cyclophosphamide plus vincristine. All of the four patients achieved complete remission again. The patient who had partial remission relapsed early and responded promptly to another course of plasma exchange plus cyclophosphamide and vincristine and achieved complete remission. CONCLUSION: Based on the results in this study, we conclude that plasma exchange plus steroids can effectively treat TTP. For patients with a refractory or relapsing disease, immunosuppressive therapy with cyclophosphamide plus vincristine should be administered as well.     

Timely thrombectomy can improve patency of hemodialysis arteriovenous fistulas

Objective

The urgency with which salvage of thrombosed vascular accesses for dialysis should be attempted remains unknown. We examined the effect of a timely thrombectomy approach on vascular access outcomes for dialysis.